Gold Silver Reports (GSR) – Gold Price Prediction, Correction Dependent on Risk Recovery : Trade developments, risk appetite and position adjustment are liable to dominate the gold price discussion during the week ahead, with the U.S. interest rate debate on hold for the very short term. Gold moved lower during the first half of the past week before reversing and posting significant net gains – with five-week highs near $1,350 per ounce – under the influence of a sharp deterioration in risk appetite.
Alembic Pharmaceuticals Gains After U.S. FDA Issues Form 483
Alembic Pharmaceuticals Gains After U.S. FDA Issues Form 483 – Shares of the Vadodara-based drug maker rose as much as 4.2 percent, the most in over a month, to Rs 557.85 after the U.S. drug regulator issued Form 483 for its Panelav facility.
Alkem Labs Gains As U.S. FDA Conducts Audit At Daman Plant
Alkem Labs Gains As U.S. FDA Conducts Audit At Daman Plant – Shares of the Mumbai-based drug maker rose as much as 2.1 percent t0 Rs 2,150 as U.S. drug regulator conducts a surprise audit at its largest facility in Daman, two people aware of the development told BloombergQuint requesting anonymity.
Stocks To Watch: Amtek, Dalmia Bharat, Fortis, JSPL, TCS
Gold Silver Reports (GSR) – Stocks To Watch: Amtek, Dalmia Bharat, Fortis, JSPL, TCS — Stocks in Asia were poised for modest advances after a rally in crude oil buoyed U.S. equities. Japan is closed for a holiday.
Modi Under Fire as Alleged $2 Billion Fraud Hits Anti-Graft Image
Gold Silver Reports (GSR) — Shortly after a $2 billion bank fraud was uncovered last month at India’s state-owned Punjab National Bank, a picture emerged of Prime Minister Narendra Modi with the alleged fraudster.